These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8480721)

  • 21. The drug therapy of ulcerative colitis and of Crohn's disease.
    Tumen HJ
    Semin Drug Treat; 1974; 3(4):339-49. PubMed ID: 4150770
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunosuppressive therapy for ulcerative colitis, ileitis, and granulomatous colitis.
    Wisch N; Korelitz BI
    Surg Clin North Am; 1972 Aug; 52(4):961-9. PubMed ID: 5047533
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunomodulator therapy of inflammatory bowel disease.
    Baert F; Rutgeerts P
    Acta Clin Belg; 1997; 52(5):251-7. PubMed ID: 9489118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study.
    Khan N; Abbas AM; Lichtenstein GR; Loftus EV; Bazzano LA
    Gastroenterology; 2013 Nov; 145(5):1007-1015.e3. PubMed ID: 23891975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporine.
    Reddy SB
    Can J Gastroenterol; 1998; 12(4):251-2. PubMed ID: 9741979
    [No Abstract]   [Full Text] [Related]  

  • 26. Azathioprine and mercaptopurine: lymphoma.
    Prescrire Int; 2011 May; 20(116):126. PubMed ID: 21648178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy of inflammatory bowel disease, including use of immunosuppressive agents.
    Korelitz BI
    Clin Gastroenterol; 1980 May; 9(2):331-49. PubMed ID: 6104550
    [No Abstract]   [Full Text] [Related]  

  • 28. Next steps on the thiopurine methyltransferase 6-thioguanine nucleotide pathway.
    Colletti RB
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):282-3. PubMed ID: 16954947
    [No Abstract]   [Full Text] [Related]  

  • 29. Azathioprine pancreatitis in inflammatory bowel disease and successful subsequent treatment with mercaptopurine.
    Alexander S; Dowling D
    Intern Med J; 2005 Sep; 35(9):570-1. PubMed ID: 16105163
    [No Abstract]   [Full Text] [Related]  

  • 30. Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease.
    Ramakrishna J; Langhans N; Calenda K; Grand RJ; Verhave M
    J Pediatr Gastroenterol Nutr; 1996 Apr; 22(3):296-302. PubMed ID: 8708884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Epstein-Barr virus-related lymphomas in patients with inflammatory bowel disease].
    Juffermans NP; Jager A; Kersten MJ; van Oers MH; Hommes DW
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1859-63. PubMed ID: 16128185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.
    Blumenstein I; Herrmann E; Filmann N; Zosel C; Tacke W; Bock H; Dignass A; Hartmann F; Zeuzem S; Stein J; Schröder O
    J Crohns Colitis; 2011 Jun; 5(3):203-10. PubMed ID: 21575882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newer treatments for inflammatory bowel disease.
    Stotland BR; Lichtenstein GR
    Prim Care; 1996 Sep; 23(3):577-608. PubMed ID: 8888346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?
    Sands BE
    Gut; 2006 Apr; 55(4):437-41. PubMed ID: 16531519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Benefits and risks of immunosuppression in chronic inflammatory bowel diseases].
    Rogler G
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1917-21. PubMed ID: 18785084
    [No Abstract]   [Full Text] [Related]  

  • 36. [New therapies for inflammatory bowel disease].
    Matsui T
    Nihon Shokakibyo Gakkai Zasshi; 2005 Jul; 102(7):855-65. PubMed ID: 16038431
    [No Abstract]   [Full Text] [Related]  

  • 37. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
    Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
    Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective.
    Axelrad JE; Roy A; Lawlor G; Korelitz B; Lichtiger S
    World J Gastroenterol; 2016 Dec; 22(46):10103-10117. PubMed ID: 28028358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is there any interest to dose the azathioprine's metabolites during inflammatory bowel diseases?].
    Melaouhia S; Fékih M; Ferchichi H; Bouissorra H; Ben Mustapha N; Boubaker J; Filali A; Lakhal M; Klouz A
    Therapie; 2013; 68(5):313-20. PubMed ID: 24225042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunosuppressive drugs in intestinal diseases (author's transl)].
    Müller-Schoop J
    Ther Umsch; 1979 May; 36(5):439-42. PubMed ID: 36684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.